azelaic acid has been researched along with metronidazole in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.00) | 18.2507 |
| 2000's | 23 (46.00) | 29.6817 |
| 2010's | 25 (50.00) | 24.3611 |
| 2020's | 1 (2.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Maddin, S | 1 |
| Del Rosso, JQ | 3 |
| Elewski, BE; Fleischer, AB; Pariser, DM | 1 |
| Wolf, JE | 2 |
| Czernielewski, J; Liu, Y | 1 |
| Lindow, KB | 1 |
| Graber, MA; van Zuuren, EJ | 1 |
| Roebuck, HL | 1 |
| Berson, DS; Nally, JB | 1 |
| Elewski, B; Thiboutot, D | 1 |
| Arsonnaud, S; Kerrouche, N; Wolf, JE | 1 |
| Gover, MD; Graber, M; Gupta, AK; Hollis, S; van Zuuren, EJ | 1 |
| Elewski, BE | 1 |
| Baum, EW; Del Rosso, JQ; Draelos, ZD; Elewski, BE; Fleischer, AB; Kakita, LS; Thiboutot, D | 1 |
| Colón, LE; Gottschalk, RW; Johnson, LA | 1 |
| Balkrishnan, R; Conde, JF; Feldman, SR; Fleischer, AB; Yelverton, CB | 1 |
| Elewski, BE; Fleischer, A; Pariser, D | 1 |
| Abdel Gawad, EH; Al Mokadem, S; El Harras, MA; Gomaa, SM; Mostafa, FF; Nassar, AA | 1 |
| Gooderham, M | 1 |
| Korting, HC; Schöllmann, C | 1 |
| Choudhary, S; Elsaie, ML | 1 |
| Berk, T; Scheinfeld, N | 1 |
| Bruce, S; Del Rosso, JQ; Jarratt, M; Menter, A; Staedtler, G | 1 |
| Kárpáti, S; Preisz, K | 1 |
| Kelsberg, G; May, D; Safranek, S | 1 |
| Carter, B; Fedorowicz, Z; Graber, MA; Kramer, S; van Zuuren, EJ | 1 |
| Cozzani, E; Drago, F; Gallo, R; Paolino, S; Parodi, A | 1 |
| Bhatia, ND; Del Rosso, JQ | 1 |
| Fallen, RS; Gooderham, M | 1 |
| Schöfer, H | 1 |
| Del Rosso, JQ; Gallo, RL; Tanghetti, E; Thiboutot, D; Webster, G | 1 |
| Keck, L; Shariff, A; Zlotoff, B | 1 |
| Berson, D; Del Rosso, JQ; Eichenfield, LF; Gallo, R; Stein-Gold, L; Tanghetti, E; Thiboutot, D; Webster, G; Zaenglein, A | 1 |
| Del Rosso, JQ; Kircik, LH | 1 |
| Carter, B; Charland, L; Fedorowicz, Z; van der Linden, MM; van Zuuren, EJ | 1 |
| Lee, GL; Zirwas, MJ | 1 |
| Asai, Y; Baibergenova, A; Barankin, B; Cochrane, CL; Humphrey, S; Lynde, CW; Marcoux, D; Poulin, Y; Rivers, JK; Sapijaszko, M; Sibbald, RG; Tan, J; Toole, J; Ulmer, M; Zip, C | 1 |
| Helfrich, YR; Maier, LM | 1 |
| Alinia, H; Feldman, SR; Fleischer, A; McGregor, SP; Snyder, A; Tuchayi, SM | 1 |
| McGee, JS; Wilkin, JK | 1 |
| Kirby, JS; Lev-Tov, H; Liu, G; Rill, JS | 1 |
| Fritsch, P; Kolber, MR; Korownyk, C | 1 |
| Cline, A; Gomolin, T; Pereira, F | 1 |
26 review(s) available for azelaic acid and metronidazole
| Article | Year |
|---|---|
A status report on the medical management of rosacea: focus on topical therapies.
Topics: Administration, Topical; Anti-Infective Agents; Anti-Infective Agents, Local; Dermatologic Agents; Dicarboxylic Acids; Drug Combinations; Humans; Metronidazole; Rosacea; Sulfacetamide; Sulfur | 2002 |
Medical treatment of rosacea with emphasis on topical therapies.
Topics: Administration, Topical; Anti-Infective Agents, Local; Clinical Trials as Topic; Dermatologic Agents; Dicarboxylic Acids; Drug Therapy, Combination; Humans; Metronidazole; Patient Compliance; Rosacea; Sulfacetamide; Sulfur; Sunscreening Agents | 2004 |
The role of topical metronidazole in the treatment of rosacea.
Topics: Administration, Topical; Anti-Infective Agents; Dicarboxylic Acids; Humans; Metronidazole; Rosacea | 2004 |
Rosacea. An overview of diagnosis and management.
Topics: Anti-Infective Agents; Body Image; Dermatologic Agents; Diagnosis, Differential; Dicarboxylic Acids; Disease Progression; Genetic Predisposition to Disease; Humans; Inflammation; Metronidazole; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Selection; Risk Factors; Rosacea; Skin Care; Social Support; Sulfacetamide; Tetracyclines | 2004 |
Present and future rosacea therapy.
Topics: Anti-Infective Agents; Biomedical Research; Chronic Disease; Dermatologic Agents; Dicarboxylic Acids; Forecasting; Humans; Metronidazole; Rosacea; Tetracycline | 2005 |
The rigor of trials evaluating Rosacea treatments.
Topics: Anti-Infective Agents; Dermatologic Agents; Dicarboxylic Acids; Gels; Humans; Metronidazole; Randomized Controlled Trials as Topic; Rosacea; Tetracycline | 2005 |
Face up to rosacea.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Dermatologic Agents; Diagnosis, Differential; Dicarboxylic Acids; Doxycycline; Humans; Laser Therapy; Life Style; Metronidazole; Minocycline; Patient Education as Topic; Referral and Consultation; Risk Factors; Rosacea; Tetracycline | 2005 |
Topical therapies for rosacea.
Topics: Administration, Topical; Dicarboxylic Acids; Humans; Metronidazole; Rosacea; Sulfacetamide | 2006 |
A clinical overview of azelaic acid.
Topics: Administration, Cutaneous; Chemistry, Pharmaceutical; Dermatologic Agents; Dicarboxylic Acids; Humans; Metronidazole; Rosacea; Severity of Illness Index | 2006 |
Systematic review of rosacea treatments.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Benzoyl Peroxide; Cosmetics; Dicarboxylic Acids; Diet; Double-Blind Method; Drug Therapy, Combination; Humans; Metronidazole; Omeprazole; Permethrin; Randomized Controlled Trials as Topic; Research Design; Rosacea; Single-Blind Method; Sunscreening Agents; Tetracyclines; Treatment Outcome | 2007 |
Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Humans; Metronidazole; Rosacea; Tetracycline | 2007 |
Current topical and systemic approaches to treatment of rosacea.
Topics: Administration, Oral; Administration, Topical; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Drug Therapy, Combination; Humans; Metronidazole; Rosacea | 2009 |
Updates on the pathophysiology and management of acne rosacea.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Dermatologic Agents; Dicarboxylic Acids; Humans; Isotretinoin; Metronidazole; Phototherapy; Rosacea; Sulfacetamide | 2009 |
A review of the diagnosis and treatment of rosacea.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Dermatologic Agents; Diagnosis, Differential; Dicarboxylic Acids; Humans; Laser Therapy; Metronidazole; Phytotherapy; Rosacea; Sunscreening Agents; Tetracycline | 2010 |
[Rosacea: pathogenesis, clinical forms and therapy].
Topics: Administration, Cutaneous; Administration, Oral; Anti-Infective Agents; Anti-Infective Agents, Local; Dermatologic Agents; Dicarboxylic Acids; Eye; Humans; Metronidazole; Rhinophyma; Rosacea; Sulfacetamide | 2010 |
Clinical inquiries. What is the most effective treatment for acne rosacea?
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Evidence-Based Medicine; Humans; Metronidazole; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Rosacea; Tetracycline; Treatment Outcome | 2011 |
Interventions for rosacea.
Topics: Anti-Infective Agents; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Humans; Metronidazole; Ophthalmic Solutions; Randomized Controlled Trials as Topic; Rosacea | 2011 |
Optimal management of papulopustular rosacea: rationale for combination therapy.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Inflammatory Agents; Dermatologic Agents; Dicarboxylic Acids; Dose-Response Relationship, Drug; Doxycycline; Drug Therapy, Combination; Humans; Inflammation; Metronidazole; Rosacea | 2012 |
An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea.
Topics: Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Humans; Immunity, Innate; Inflammation; Low-Level Light Therapy; Metronidazole; Rosacea; Skin; Telangiectasis; Th1 Cells; Toll-Like Receptor 2; Vasodilation | 2013 |
Interventions for rosacea.
Topics: Anti-Infective Agents; Brimonidine Tartrate; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Ivermectin; Male; Metronidazole; Middle Aged; Ophthalmic Solutions; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea; Tetracycline | 2015 |
Granulomatous Rosacea and Periorificial Dermatitis: Controversies and Review of Management and Treatment.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Benzoyl Peroxide; Dermatitis, Perioral; Dermatologic Agents; Dicarboxylic Acids; Facial Dermatoses; Humans; Lasers, Dye; Low-Level Light Therapy; Metronidazole; Photochemotherapy; Rosacea; Skin; Toothpastes; Ultraviolet Rays | 2015 |
Canadian Clinical Practice Guidelines for Rosacea.
Topics: Anti-Infective Agents; Consensus; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Eye Diseases; Humans; Intense Pulsed Light Therapy; Isotretinoin; Ivermectin; Laser Therapy; Metronidazole; Outliers, DRG; Practice Guidelines as Topic; Rosacea; Tetracycline | 2016 |
Topical and oral therapeutic approach to rosacea.
Topics: Administration, Cutaneous; Administration, Oral; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Evidence-Based Medicine; Humans; Ivermectin; Metronidazole; Rosacea; Treatment Outcome | 2016 |
A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.
Topics: Administration, Cutaneous; Anti-Infective Agents; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Humans; Ivermectin; Metronidazole; Rosacea | 2018 |
Rosacea First-choice treatments.
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic alpha-2 Receptor Agonists; Anti-Bacterial Agents; Antiparasitic Agents; Azithromycin; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Humans; Ivermectin; Metronidazole; Rosacea | 2017 |
Treatment of rosacea during pregnancy.
Topics: Adult; Algorithms; Animals; Anti-Bacterial Agents; Azithromycin; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Isotretinoin; Ivermectin; Metronidazole; Mice; Minocycline; Phototherapy; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Rosacea; Tetracyclines; Treatment Outcome | 2021 |
7 trial(s) available for azelaic acid and metronidazole
| Article | Year |
|---|---|
A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea.
Topics: Administration, Topical; Adult; Aged; Dermatologic Agents; Dicarboxylic Acids; Double-Blind Method; Humans; Metronidazole; Middle Aged; Ointments; Patient Satisfaction; Rosacea | 1999 |
A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Dermatologic Agents; Dicarboxylic Acids; Double-Blind Method; Erythema; Female; Gels; Humans; Male; Metronidazole; Middle Aged; Osmolar Concentration; Patient Satisfaction; Rosacea; Telangiectasis; Treatment Outcome | 2003 |
Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.
Topics: Administration, Cutaneous; Adult; Aged; Dermatologic Agents; Dicarboxylic Acids; Drug Administration Schedule; Female; Gels; Humans; Male; Metronidazole; Middle Aged; Patient Satisfaction; Rosacea; Severity of Illness Index; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome; United States | 2006 |
Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%.
Topics: Administration, Topical; Adult; Dermatologic Agents; Dicarboxylic Acids; Drug Eruptions; Female; Gels; Humans; Male; Metronidazole; Middle Aged; Rosacea; Single-Blind Method | 2007 |
Comparative study of some treatment modalities of rosacea.
Topics: Adult; Dicarboxylic Acids; Double-Blind Method; Female; Humans; Male; Metronidazole; Middle Aged; Permethrin; Rosacea | 2009 |
Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Dicarboxylic Acids; Doxycycline; Drug Therapy, Combination; Female; Gels; Humans; Male; Metronidazole; Middle Aged; Rosacea | 2010 |
Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Delayed-Action Preparations; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Male; Metronidazole; Middle Aged; Rosacea; Severity of Illness Index; Sulfacetamide; Treatment Outcome | 2010 |
17 other study(ies) available for azelaic acid and metronidazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Comparison of 15% azelaic acid gel and 0.75% metronidazole gel for the topical treatment of papulopustular rosacea.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Dermatologic Agents; Dicarboxylic Acids; Gels; Humans; Metronidazole; Rosacea; Severity of Illness Index | 2004 |
Rosacea trial comparing twice-daily azelaic acid gel 15% with once-daily metronidazole gel 1%.
Topics: Anti-Infective Agents; Dermatologic Agents; Dicarboxylic Acids; Drug Administration Schedule; Humans; Metronidazole; Rosacea; Safety; Treatment Outcome | 2007 |
Azelaic acid gel 15%: clinical versatility in the treatment of rosacea.
Topics: Dermatologic Agents; Dicarboxylic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emollients; Gels; Humans; Metronidazole; Rosacea; Skin Care; Soaps; Sunscreening Agents | 2006 |
In reference to the October 2004 comprehensive overview of rosacea therapy.
Topics: Clinical Trials as Topic; Dermatologic Agents; Dicarboxylic Acids; Humans; Metronidazole; Rosacea | 2007 |
Rosacea and its topical management.
Topics: Administration, Cutaneous; Dermatologic Agents; Dicarboxylic Acids; Humans; Metronidazole; Rosacea; Sulfacetamide | 2009 |
[Treatment of rosacea].
Topics: Adapalene; Anti-Infective Agents; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Humans; Immunosuppressive Agents; Isotretinoin; Keratolytic Agents; Metronidazole; Mite Infestations; Naphthalenes; Rosacea; Sulfacetamide; Tacrolimus; Tetracycline; Toluidines; Tretinoin | 2011 |
Rosacea: update on management and emerging therapies.
Topics: Administration, Cutaneous; Adrenergic Agents; Anti-Infective Agents; Antiparasitic Agents; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Ivermectin; Male; Metronidazole; Oxymetazoline; Quality of Life; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea; Sulfacetamide; Treatment Outcome | 2012 |
[Topical therapy of rosacea].
Topics: Administration, Topical; Anti-Inflammatory Agents; Dermatologic Agents; Dicarboxylic Acids; Humans; Injections, Intravenous; Metronidazole; Rosacea; Steroids | 2013 |
Acne vulgaris in the context of complex medical co-morbities: the management of severe acne vulgaris in a female with retinitis pigmentosa - utilizing pulse dye laser in conjunction with medical therapy.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Androstenes; Anti-Infective Agents, Local; Combined Modality Therapy; Contraindications; Dapsone; Dicarboxylic Acids; Ethinyl Estradiol; Female; Humans; Lasers, Dye; Metronidazole; Mineralocorticoid Receptor Antagonists; Photosensitizing Agents; Retinal Detachment; Retinitis Pigmentosa; Rosacea; Sulfacetamide; Telangiectasis | 2014 |
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea.
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic alpha-2 Receptor Agonists; Anti-Infective Agents; Brimonidine Tartrate; Consensus; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Erythema; Humans; Metronidazole; Quinoxalines; Rosacea; Severity of Illness Index; Societies, Medical | 2014 |
Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid.
Topics: Administration, Cutaneous; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Drug Therapy, Combination; Gels; Humans; Metronidazole; Rosacea | 2014 |
Ivermectin cream for rosacea.
Topics: Adult; Clinical Trials as Topic; Dicarboxylic Acids; Drug Interactions; Humans; Ivermectin; Metronidazole; Ointments; Rosacea | 2015 |
Prescription to Over-the-Counter Switch of Metronidazole and Azelaic Acid for Treatment of Rosacea.
Topics: Anti-Infective Agents; Dermatologic Agents; Diagnostic Self Evaluation; Dicarboxylic Acids; Humans; Metronidazole; Nonprescription Drugs; Prescription Drugs; Rosacea; Self Care | 2018 |
Trends in utilization of topical medications for treatment of rosacea in the United States (2005-2014): A cohort analysis.
Topics: Administration, Cutaneous; Adult; Anti-Bacterial Agents; Cohort Studies; Dermatologic Agents; Dicarboxylic Acids; Drug Costs; Drug Therapy, Combination; Drug Utilization; Drugs, Generic; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Rosacea; United States | 2019 |
Topical treatments for rosacea.
Topics: Administration, Topical; Dicarboxylic Acids; Drug Costs; Humans; Ivermectin; Metronidazole; Patient Reported Outcome Measures; Rosacea | 2019 |